Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|October 26, 2001
Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2AA McCluskey, C Walkom, M C Bowyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2002
Phase II trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancerS J Clarke, R Abratt, L Goedhals, et al.
Blood|January 1, 1987
Evidence favoring lineage fidelity in acute nonlymphocytic leukemia: absence of immunoglobulin gene rearrangements in FAB types M4 and M5S P Ackland, C A Westbrook, M O Diaz, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Pharmacokinetics and pharmacodynamics of long-term continuous-infusion doxorubicinS P Ackland, M J Ratain, N J Vogelzang, et al.
Scandinavian Journal of Haematology|January 1, 1984
The biochemical and clinical consequences of 2'-deoxycoformycin in T cell chronic lymphocytic leukaemiaL J Hallam, M B Van der Weyden, S P Ackland, et al.
European Journal of Cancer (Oxford, England : 1990)|June 26, 1998
Comparison of 5-fluoro-2'-deoxyuridine with 5-fluorouracil and their role in the treatment of colorectal cancerJ A van Laar, Y M Rustum, S P Ackland, et al.
British Journal of Cancer|September 20, 2012
Predicting 5-fluorouracil toxicity in colorectal cancer patients from peripheral blood cell telomere length: a multivariate analysisM B Garg, L F Lincz, K Adler, et al.
Bone Marrow Transplantation|July 20, 2004
Telomere length predicts neutrophil recovery in the absence of G-CSF after autologous peripheral blood stem cell transplantationL F Lincz, F E Scorgie, J A Sakoff, et al.
British Journal of Cancer|January 24, 2007
Mechanism of trifluorothymidine potentiation of oxaliplatin-induced cytotoxicity to colorectal cancer cellsO H Temmink, E K Hoebe, K van der Born, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Causes for increased myelosuppression with increasing age in patients with oesophageal cancer treated by chemoradiotherapyJ W Denham, S P Ackland, B Burmeister, et al.
Pageof 4